Development of a Recombinant Single-Cycle Influenza Viral Vector as an Intranasal Vaccine against SARS-CoV-2 and SARS-like Betacoronaviruses.

Munro J., Melnyk D., Afzal M., Schimanski L., Cohen AA., Keeffe JR., Bjorkman PJ., James WS., Townsend AR., Tan TK.

DOI

10.1101/2025.11.28.691177

Type

Preprint

Publication Date

2025-12-01T00:00:00+00:00

Keywords

SARS-CoV-2, influenza, non-replicating viral vector, vaccine

Permalink More information Close